Cytoreductive nephrectomy in metastatic renal cell carcinoma.

about

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q36573863

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

@ast

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

@en

type

Item

label

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

@ast

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

@en

prefLabel

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

@ast

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

@en

P1476

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

@en

P2093

Fray F Marshall

http://www.w3.org/2001/XMLSchema#string

Kelly A Healy

http://www.w3.org/2001/XMLSchema#string

Kenneth Ogan

http://www.w3.org/2001/XMLSchema#string

P2860

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis.

Should radical nephrectomy be performed in the face of surgically incurable disease?

Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma?

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

Novel approaches in the therapy of metastatic renal cell carcinoma.

Recent advances in kidney cancer and metastatic disease.

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

P304

1295-1304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.6.8.1295

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6863695

http://www.w3.org/2001/XMLSchema#string

P698

16925495

http://www.w3.org/2001/XMLSchema#string